Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N4PC
|
||||
Former ID |
DIB011215
|
||||
Drug Name |
RU-46556
|
||||
Indication | Endometrial cancer [ICD9: 182; ICD10:C54.1] | Terminated | [545435] | ||
Company |
Aventis Pharma AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C12=C3C(=CC(=O)CC3)CC[C@H]1[C@H]1[C@](C[C@@H]2c2ccc(SC)<br />cc2)([C@@]2(OCC=C2)CC1)C
|
||||
CAS Number |
CAS 116680-11-6
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | Modulator | [533113] | |
KEGG Pathway | Oocyte meiosis | ||||
Progesterone-mediated oocyte maturation | |||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.